Elsevier

Bone

Volume 29, Issue 2, August 2001, Pages 121-125
Bone

Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice

https://doi.org/10.1016/S8756-3282(01)00486-0Get rights and content

Abstract

Prostaglandins play an important role in regulating the bone adaptation response to mechanical stimuli. Prostaglandin E2 (PGE2) is an effective modulator of bone metabolism. Administration of PGE2 to rodents results in increased cancellous and cortical bone mass translating into enhanced mechanical strength. The PGE2 influence on bone is mediated through four well-characterized receptors (EP1, EP2, EP3, and EP4). Although the PGE2 pathways and mechanisms of action on cells involved in bone adaptation are still under investigation, it is now known that each receptor plays a unique role in regulating PGE2-related bone cell function. The EP1 subtype is coupled with Ca2+ mobilization. The EP2 subtype stimulates cyclic adenosine monophosphate (cAMP) formation. cAMP in turn is responsible for the early cellular signal that stimulates bone formation. This study compared physical and biomechanical properties of bone in EP1 and EP2 knockout mice to their corresponding wild-type controls. Ash weight was measured in the ulnae, and femurs and vertebral bodies were tested in three-point bending and compression, respectively. The results suggest: (a) EP1 receptors have a minimal influence on skeletal strength or size in mice; and (b) EP2 receptors have a major influence on the biomechanical properties of bone in mice. The absence of EP2 receptors resulted in weak bone biomechanical strength properties in the EP2 knockout model as compared with the corresponding wild-type control mice.

Introduction

Prostaglandins are strong modulators of bone metabolism and their administration to rodents results in increased cancellous and cortical bone mass translating into enhanced mechanical strength of the skeleton.35 Among the many prostaglandins, the E series, prostaglandin E2 (PGE2), has proven to be a potent systemic1, 14, 15, 16, 17, 18, 19, 23, 24, 27, 37, 41 and local bone anabolic agent.30, 43 Treatment with PGE2 results in substantial production of new bone manifested by increased osteoblast numbers and labeled surfaces in animal,14, 18, 19, 23 and human20 studies. In addition, PGE2 is known to have a biphasic effect on osteoblast cell lines9, 28, 29 with cell differentiation seen at low concentrations and cell proliferation seen at high concentrations. However, the mechanism of action of PGE2 on bone tissue is not fully understood and is still under investigation.

PGE2 has multiple effects on biological activities in bone and is mediated through various receptors. For example, PGE2 stimulates bone formation and resorption through osteoblastic and osteoclastic activities, respectively. The effects of PGE2 are mediated by four well-characterized receptors (EP1– EP4).4, 7, 10, 13, 22, 25, 26, 32, 34, 39, 42 These PGE2 receptors have been cloned and phenotyped in humans,4, 22 rats,32 dogs,11 and mice.13, 34, 42 Each EP receptor has a unique intracellular signaling pathway in bone. For instance, EP1 is coupled with intracellular Ca2+ transport, whereas EP3 blocks cellular adenylate cyclase.21, 34, 42 On the other hand, EP2 and EP4 receptors stimulate cellular adenylate cyclase to accumulate cellular cAMP in osteoblast and osteoclast cells,25, 26, 31, 36, 39, 44 thus affecting bone metabolism. Similar to EP2 the EP4 receptor also plays a major role in stimulating bone resorption through increased osteoclast numbers as observed in mouse calvaria cultures.31, 36

Recent in vitro data8 from young rat calvaria cells suggest that the PGE2-related effects on osteoblast proliferation and differentiation (resulting bone nodules) were mediated through the EP1 receptor. PGE2 enhanced bone nodule formation and alkaline phosphatase (ALP) activity in osteoblast cells mediated through EP1 receptors.8 On the other hand, PGE2 analogs, acting through the EP2/EP4 receptor, had an opposite effect on osteoblast cells, resulting in reduced bone nodule formation and ALP activity but enhanced cell proliferation.8 In addition, PGE2 also affects other biological systems through the EP2 receptor, causing decreased blood pressure and low fertility in female EP2 knockout mice.38 Absence of either of these receptors (EP1 and EP2) may interrupt specific PGE2 pathways and thus directly or indirectly affect bone physical and mechanical properties.

This study compares bone physical and biomechanical properties in EP1 and EP2 knockout mice to their corresponding wild-type controls. We examined both axial (vertebrae) and appendicular (femurs, ulnae) bones from adult mice.

Section snippets

Materials and methods

We examined bone biomechanical properties in two sets of adult (4 months of age) female mice. These included: (a) EP1 knockout (n = 12), and wild-type control (DBAl/lacJ) (n = 13) animals;38 and (b) mice heterozygous for a targeted disruption of the EP2 gene38 crossed with C57BL/6 × DBA/2 F1 then intercrossed to produce homozygous EP2 knockout (n = 20) and wild-type control (n = 21) animals. At autopsy, the femurs, vertebral bodies, and ulnae were collected and frozen in saline at −20°C for

Results

The physical properties, including body weight, femoral length, femoral diaphysis total cross-sectional area, marrow area, cortical area, second moment of area, ulnar dry and ash weights, and vertebral body height were not different between the EP1 knockout and corresponding wild-type control mice (Table 1). However, the vertebral body cross-sectional area in the EP1 knockout mice was greater than in wild-type controls. Body weight, diaphyseal total area, and marrow area in the femurs and

Discussion

We investigated the action of PGE2 receptors, EP1 and EP2, on the physical and biomechanical properties of ulnae, femurs, and vertebral bodies from EP1 and EP2 knockout mice by comparing them with their corresponding wild-type controls. The majority of the physical (except for the vertebral body cross-sectional area) and biomechanical properties of the EP1 knockout and corresponding wild-type controls were similar. Although most of the values for physical properties were higher, the

Conclusions

This study has found that EP1 receptors are not essential for skeletal strength but do have some site-specific effect on bone size. The absence of EP1 receptors resulted in greater vertebral cross-sectional area in EP1 knockout mice as compared with wild-type control mice. We also found that EP2 receptors have a major influence on the biomechanical properties of bone in mice. The absence of EP2 receptors resulted in weak bone biomechanical strength properties and greater bone size in the EP2

Acknowledgements

This work was supported by NIH Grant 12556. The authors thank Dr. Lydia Pan (Pfizer, Inc., Central Research, Groton, CT) for providing all of the mice used in these studies. We also thank Amy Peyton and Mark Covey for assistance in specimen collection and preparation for testing.

References (44)

  • L.G. Raisz

    Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism

    J Nutr

    (1995)
  • L.G. Raisz et al.

    Prostaglandin synthesis by fetal rat bone in vitroEvidence for a role of prostacyclin

    Prostaglandins

    (1979)
  • Y. Sugimoto et al.

    Cloning and expression of cDNA for mouse prostaglandin E receptor EP3 subtype

    J Biol Chem

    (1992)
  • K. Toriyama et al.

    The existence of different classes of prostaglandin E2 receptors mediating adenylate cyclase and phospholipase C pathways in osteoblstic clone MC3T3-E1

    Prostagland Leuk Essen Fatty Acids

    (1992)
  • K. Ueno et al.

    The effects of prostaglandin E2 in rapidly growing ratsDepressed longitudinal and radial growth and increased metaphyseal hard tissue mass

    Bone

    (1985)
  • A. Watabe et al.

    Cloning and expression cDNA for a mouse prostaglandin E receptor EP1 subtype of prostaglandin

    J Biol Chem

    (1993)
  • Akamine, T., Jee, W. S. S., Ke, H. Z., Li, X. J., and Lin, B. Y. PGE2 prevents bone loss and adds extra bone to...
  • M.P. Akhter et al.

    Genetic variations in bone density, histomorphometry, and strength in mice

    Calcif Tissue Int

    (2000)
  • Baumeister, T. and Avallone, E. A. Mark’s Standard Handbook for Mechanical Engineers, 10th Ed. New York. McGraw-Hill;...
  • R.A. Coleman et al.

    EP4-receptors and cyclic AMP in pig venous smooth muscleevidence with agonists and the EP4-antagonist

    Adv Prostagland Thrombo Leuk Res

    (1995)
  • M. Fujieda et al.

    Formation of mineralized bone nodules by rat calvarial osteoblasts decreases with donor age due to a reduction in signaling through EP(1) subtype of prostaglandin E(2) receptor

    J Cell Biochem

    (1999)
  • Y. Hakeda et al.

    Prostaglandin E2 stimulates DNA synthesis by cyclic AMP-independent pathway in osteoblastic clone MC3T3-E1 cells

    J Cell Physiol

    (1986)
  • Cited by (0)

    View full text